Company Profiles

driven by the PitchBook Platform

Metaclipse Therapeutics

Description

Operator of a pre-clinical stage biotechnology company. The company is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with proven immunostimulatory molecules.

2011

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$200k

Total Amount Raised

7

Investors

Description

Operator of a pre-clinical stage biotechnology company. The company is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with proven immunostimulatory molecules.

Website:

www.metaclipse.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Therapeutic Devices

Primary Office

3175 Presidential Drive Atlanta, GA 30340United States +1 (404) 380-1342
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Metaclipse Therapeutics's full profile, request a free trial.

Metaclipse Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Metaclipse Therapeutics Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biotechnology and Biological Science Research CouncilLimited Partner000 0000000 0000
Georgia Research AllianceGovernment000 0000000 0000
GRA Venture FundVenture CapitalMinority000 0000000 0000
JLabsAccelerator/Incubator000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
Biotechnology and Biological Science Research Council Limited Partner
Georgia Research Alliance Government
GRA Venture Fund Venture Capital
JLabs Accelerator/Incubator
National Cancer Institute Government

Metaclipse Therapeutics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Shaker ReddyCo-Founder, President, Chief Operating Officer & Board Member
Periasamy Selvaraj Ph.DChief Scientific Officer & Co-Founder
Kamal Kannan Ph.DVice President, Product Development & Consultant
Dawn Eberhardt Ph.DDirector of Quality Control
Shaker Reddy Co-Founder, President, Chief Operating Officer & Board Member
Periasamy Selvaraj Ph.D Chief Scientific Officer & Co-Founder
Kamal Kannan Ph.D Vice President, Product Development & Consultant
Dawn Eberhardt Ph.D Director of Quality Control

Metaclipse Therapeutics Board Members (1)

NameRepresentingRoleSinceContact
Info
Shaker ReddyMetaclipse TherapeuticsCo-Founder, President, Chief Operating Officer & Board Member000 0000
Shaker Reddy Co-Founder, President, Chief Operating Officer & Board Member Metaclipse Therapeutics
Request full access to PitchBook